Nestle India and Zydus Wellness shares hit six-month low after food regulator notices

what happened

Nestle India shares fell about 3.7 percent on Thursday, October 21, to a six-month low of Rs 1,187.10. Zydus Wellness shares dropped more than 3 percent, sliding below Rs 477.10. The pressure followed notices from the Food Safety and Standards Authority of India (FSSAI) over what it called misleading claims on certain products, with both companies asked to provide scientific proof for their advertising. The report was published by TradingView.

For Nestle India's Lactogen Pro 1 powder, the regulator questioned a label claim that its whey protein is easy to digest and requested substantiation. For Nan Excella Pro Stage 1, it found an immune-support claim non-compliant. Zydus Wellness received a notice over Complan claims such as "2X Faster Growth," and was asked to justify them and show cause. Nestle India said it had already submitted a detailed response on the labelling issue.

why it matters

For markets this looks like a targeted regulatory risk rather than a sector-wide shock, but possible penalties could weigh on sales of children's and nutrition products. The share declines also left Nestle India as the biggest drag on the Nifty FMCG index.

market impact

Indian consumer sector: advertising-related regulatory risk pressures Nestle India and Zydus Wellness shares

tags

instruments